Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine as an adjuvant to chirocaine in retrobulbar block for ophthalmic surgery
NL-OMON36352Phase 3Active, not recruiting
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rhegmatogenous retinal detachment (RRD) and Glaucoma comparing Clonidine + Chirocaine retrobulbar block with Control retrobulbar block with Chirocaine (2 arms). Primary endpoints: Maximal pain level, Time of maximal post-operative pain and 2 more. Started Jul 2011; status: active, not recruiting.
02
Drugs
clonidinelevobupivacaine
03
Conditions
rhegmatogenous retinal detachment (RRD)Glaucoma
Beyond the preview
Go deeper on NL-OMON36352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36352.